Product
MK-7762
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Trial in Healthy Adults to Evaluate the Safety, Tolerability, and PK of MK-7762Status: Recruiting, Estimated PCD: 2024-10-16